AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga Grant

AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga Grant

Status: ACTIVE
Funder: American Association for Cancer Research
Amount: US $300,000
Last Updated: February 27, 2026

Summary

Overview

Note: The AACR requires applicants to complete an online Letter of Intent submission by the deadline indicated above for Letter of Inquiry. By the Letter of Intent submission deadline, applicants must be AACR Active members in good standing (dues paid for the current year). Applicants whose membership is not in good standing or nonmembers who do not apply for membership by the Letter of Intent submission deadline will be considered ineligible. American Association for Cancer Research The American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the conquest of cancer. Mission The mission of the American Association for Cancer Research is to prevent and cure cancer through: Research Education Communication Collaboration Science Policy and Advocacy Funding for Cancer Research Through its programs and services, the AACR fosters research in cancer and related biomedical science; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world. AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga The AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga was established to honor the life and legacy of Dr. José Baselga, who was a scientific leader and supportive mentor to an entire generation of physician-scientists. Dr. Baselga’s research focused on novel molecular targeted therapeutics and he played a leading role in the clinical development of multiple cancer drugs. The intent of this program is to encourage and support early-career physician-scientists to conduct research and bolster the development of innovative targeted therapeutics. The proposed projects may be translational, clinical, or population sciences in nature and focused on all aspects of oncology.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.